Sunjay is a partner in Osborne Clarke's London office, part of a growing group of expert Corporate lawyers.

He delivers commercially-focused advice to public companies, high-growth businesses and their investors.

He specialises in capital markets transactions, M&A and private capital financings, with a particular focus on the Life Sciences and Tech sectors. Sunjay also advises university-affiliated investment vehicles on their establishment; agreements with academic institutions; private capital fundraising from institutional investors and subsequent investment of these funds into IP-rich spin-out companies.

With his specialism in Life Sciences, Sunjay advises a range of clients across the sector, from companies listed on the Main Market and AIM to spin-outs, high-growth companies and their investors.

Sunjay has advised on both the buy-side and sell-side of M&A transactions in the Life Sciences sector. His experience ranges from major asset disposals and acquisitions for publicly-listed pharmaceutical companies, to M&A for private biotech and medtech clients.

Sunjay has advised corporates and investment banks on a variety of public transactions, including IPOs and secondary offerings (both on the Main Market and AIM), takeovers, and step-ups to the Main Market. He also has experience advising on shareholder activism (both from a company and an activist perspective), as well as advising boards more generally their day-to-day corporate governance requirements, including compliance with the Market Abuse Regulation.

A particular niche is Sunjay's work in the university investment vehicle space. He is the only lawyer to have advised on the establishment and private capital fundraising of four such vehicles in the UK, including Oxford Science Enterprises, Cambridge Innovation Capital, Northern Gritstone and Midlands Mindforge.

Sunjay champions a relationship-driven practice, ensuring his advice is aligned to, and helps his clients achieve, their strategic objectives